Independent Research Reiterates €72.00 Price Target for Gerresheimer (GXI)

Share on StockTwits

Gerresheimer (ETR:GXI) has been given a €72.00 ($83.72) price target by analysts at Independent Research in a research report issued on Thursday. The firm currently has a “neutral” rating on the stock. Independent Research’s price target points to a potential upside of 8.93% from the company’s previous close.

A number of other research firms have also weighed in on GXI. Kepler Capital Markets set a €65.00 ($75.58) target price on Gerresheimer and gave the stock a “sell” rating in a report on Thursday, July 12th. equinet set a €69.00 ($80.23) price objective on Gerresheimer and gave the company a “neutral” rating in a report on Thursday, July 12th. Commerzbank set a €68.00 ($79.07) price objective on Gerresheimer and gave the company a “neutral” rating in a report on Thursday, July 12th. JPMorgan Chase & Co. set a €79.40 ($92.33) price objective on Gerresheimer and gave the company a “neutral” rating in a report on Thursday, July 12th. Finally, Goldman Sachs Group set a €70.00 ($81.40) price objective on Gerresheimer and gave the company a “neutral” rating in a report on Thursday, July 12th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. Gerresheimer currently has an average rating of “Hold” and a consensus price target of €71.92 ($83.62).

GXI stock opened at €66.10 ($76.86) on Thursday. Gerresheimer has a 1-year low of €59.97 ($69.73) and a 1-year high of €78.25 ($90.99).

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

See Also: What are the reasons investors use put options?

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply